Elevated risk for iron depletion in high-school age blood donors
- PMID: 30633813
- PMCID: PMC6499707
- DOI: 10.1111/trf.15133
Elevated risk for iron depletion in high-school age blood donors
Abstract
Background: High school students 16 to 18 years-old contribute 10% of the US blood supply. Mitigating iron depletion in these donors is important because they continue to undergo physical and neurocognitive development.
Study design and methods: Study objectives were to determine the prevalence of iron depletion in 16- to 18-year-old donors and whether their risk for iron depletion was greater than adult donors. Successful, age-eligible donors were enrolled from high school blood drives at two large US blood centers. Plasma ferritin testing was performed with ferritin less than 12 ng/mL as our primary measure of iron depletion and ferritin less than 26 ng/mL a secondary measure. Multivariable repeated-measures logistic regression models evaluated the role of age and other demographic/donation factors.
Results: Ferritin was measured from 4265 enrollment donations September to November 2015 and 1954 follow-up donations through May 2016. At enrollment, prevalence of ferritin less than 12 ng/mL in teenagers was 1% in males and 18% in females making their first blood donation, and 8% in males and 33% in females with prior donations. Adjusted odds for ferritin less than 12 ng/mL were 2.1 to 2.8 times greater in 16- to 18-year-olds than in 19- to 49-year-olds, and for ferritin less than 26 ng/mL were 3.3- to 4.7-fold higher in 16- to 18-year-olds. Progression to hemoglobin deferral was twice as likely in 16- to 18-year-old versus 19- to 49-year-old females.
Conclusion: Age 16 to 18 years-old is an independent risk factor for iron deficiency in blood donors at any donation frequency. Blood centers should implement alternate eligibility criteria or additional safety measures to protect teenage donors from iron depletion.
© 2019 AABB.
Conflict of interest statement
Conflict of Interest: AEM receives research grant funding from Novo Nordisk. The other authors have no competing interests.
Figures







Comment in
-
Iron replacement: precautionary principle versus risk-based decision making.Transfusion. 2019 May;59(5):1613-1615. doi: 10.1111/trf.15274. Transfusion. 2019. PMID: 31050828 No abstract available.
-
Iron supplementation? Ferritin screening? Why questions persist.Transfusion. 2019 May;59(5):1616-1619. doi: 10.1111/trf.15303. Transfusion. 2019. PMID: 31050829 No abstract available.
References
-
- Eder AF, Crowder LA, Steele WR. Teenage blood donation: demographic trends, adverse reactions, and iron balance. ISBT Sci Series. 2017;12:395–400.
-
- U.S. National Institutes of Health, Office of Dietary Supplements. Iron fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional. Accessed 13 August 2018.
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- HHSN268201100006I/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical